Colinz Laboratories is in the business of manufacturing and trading in pharmaceutical formulationsBusiness Overview: http://www.colinz.com/about.html CLL is a manufacturer and exporter of pharmaceutical formulations for allopathic, ayurvedic, nutraceticals in dosage forms of tablets, capsules, ointments, creams, granules, liquid, orals, injectables, syrups, suppsitories, etc. It also has certain specialized products…
Colinz Laboratories Limited has announced its 40th Annual General Meeting (AGM) will be held via Video Conferencing on September 22. Shareholders will transact business as per the AGM notice, which was sent electronically. The company provides an e-voting facility, with the cut-off date for determining eligible voters being September 15....
Colinz Laboratories has announced a board meeting held on 30th July, 2026, where the audited financial results for the quarter ended 30th June, 2026, and the year ended 31st March, 2026, were approved. For the quarter, revenue from operations was 1.36 Cr, with a net profit of 2.40 Cr and...
Colinz Laboratories has received a certificate from its Registrar and Share Transfer Agent confirming the proper handling of share dematerialization requests for the quarter ended June 30, 2026. The certificate verifies that all physical share certificates submitted for conversion to electronic format were processed accurately, ensuring new electronic shares are...
Colinz Laboratories has clarified its exemption from certain corporate governance reporting for the recent quarter. This is because its paid-up equity capital was below Rs 10 Crore (2.52 Cr) and net worth was below Rs 25 Crore (10.04 Cr) at the end of the previous financial year. This exemption, based...
Colinz Laboratories has announced that a specific compliance regulation, which requires companies to report on the utilization of funds from public, rights, preferential issues, or QIPs, is not applicable to the company. This is because Colinz has not undertaken any such capital raising activities. This serves as a standard compliance...
